Reach Us +1-504-608-239
M Di Bartolomeo | OMICS International
ISSN: 2577-0535

Journal of Cancer Clinical Trials
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Relevant Topics

M Di Bartolomeo

Fondazione IRCCS Istituto Nazionale Tumori Via Venezian, Milan

Osteopontin Expression and its Potential Role as Prognostic Factor and Therapeutic Target for Gastric Cancer

A correlation between the over expression of Osteopontin (OPN), E-cadherin, β-catenin, and cyclooxygenase 2 and poor prognosis has been previously suggested in solid tumors. The aim of the ITACA-S translational study was to further investigate the correlation of these immunohistochemical biomarkers with the outcome of radically resected gastri... Read More»

F Morano and M Di Bartolomeo

Commentary: J Cancer Clin Trials 2:136

Abstract Peer-reviewed Full Article Peer-reviewed Article PDF Mobile Full Article